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A B S T R A C T
Down syndrome (DS) is the most common genetic cause of mental retardation. It is estimated that 5–13% of persons
affected by DS have seizures. Infantile spasms are the most common type of seizures and usually are well controlled with
steroids and antiepileptic drugs. We present 11 children at the age of 3 years and 4 months to 10 years and 7 months with
DS and infantile spasms, treated at Children’s Hospital Zagreb from January 2000 until July 2009. Infantile spasms be-
gan at the age of 5 to 10.5 months in 10 children, in one child at the age of 16 months. Only one child had perinatal risk
factors for the development of IS. Changes in EEG correlated to hypsarrhythmia. Infantile spasms were treated initially
with antiepileptic drugs, most often with valproic acid. Treatment was inefficient in 10/11 patients. After application of
ACTH, infantile spasms stopped between 7 and 15 days in 6 patients, until 28th day in 4 patients. Hypsarrhythmia van-
ished in all children. During follow-up period (2 years and 7 months to 9 years and 5 months) none of the children devel-
oped another type of seizures. No major epileptogenic changes were registered in EEG. Antiepileptic therapy was discon-
tinued in 4 children (aged 4 years and 2 months to 5 years). In this group is the boy who died of heart failure. Infantile
spasms associated with DS are categorized into symptomatic group. The existence of cerebral pathology and delayed psy-
cho-motor development precedes occurrence of seizures. It is possible to achieve good control of seizures and disappear-
ance of hypsarrhythmia with application of ACTH and antiepileptic drugs.
Key words: infantile spasms, Down syndrome, antiepileptic drugs, hypsarrhythmia, ACTH
Introduction
Down syndrome (DS) is the most common genetic
cause of intellectual disability. It is a chromosomal disor-
der caused by defect in cell splitting. In 95% of the pa-
tients exists a regular form of trisomy 21 caused by in-
herent chromosomes, translocation form in 3–4% and
the mosaic form in 1–2% of patients. In addition to the
typical phenotypic features and intellectual disability, in
patients with DS there is greater incidence of congenital
hypothyroidism, deafness, congenital heart defects, vi-
sual disturbances, immune deficits and malignant dis-
ease than the general population. It is estimated that
5–13% of persons suffering from DS have convulsions1–4.
Higher incidence is found in children younger than one
year2. Particularly high is the incidence of infantile spa-
sms1–5. Among the etiological factors associated with in-
fantile spasms (IS), 1% belongs to DS6. Infantile spasms
in DS can be subtle or very mild, which makes diagnosing
somewhat difficult7. Although the IS in children with DS
are categorized in symptomatic group, by implementing
antiepileptic drugs and adrenocorticotropic hormone
(ACTH), good control of seizures and disappearance hy-
psarrhythmia is achieved4,5,8,9.
The aim of this paper is to present 11 children with
Down syndrome who had IS seizure type, their course of
disease, the effect of corticosteroid therapy and outcome.
Materials and Methods
Since January 2000 – July 2009 in Zagreb Children’s
Hospital, 11 children (9 male and 2 female) suffering
from Down’s syndrome have been treated. All children
were referred to the Clinic because of infantile spasms.
Five children began treatment in other hospitals, prior
admittance to our hospital. Despite oral antiepileptic
therapy they received (valproic acid, vigabatrin, topira-
mate, lamotrigine), seizures repeated, and they were re-
ferred to our Clinic for corticosteroid therapy.
The children are now at the age of 3 years and 4
months to 10 years and 7 months. All patients were pro-
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spectively followed during period of 2 years and 7 months
to 9 years and 5 months. Follow-up of one boy aged 4
years and 3 months was discontinued because of death.
Results
Clinical characteristics of our patients are shown in
Table 1. Ten children were born after full gestation and
one child was born in the 34th week of gestation (patient
1). Two children had intrauterine growth retardation,
one of them with heart defect AV canalis communis (pa-
tient 6), and the other with pulmonary artery stenosis,
hemodynamically insignificant (patient 10). Assessment
of the vitality of newborn in the 1st and 5th minute after
birth was made using the Apgar score. One child with AV
canalis communis heart disease had abnormal Apgar
score in 1st and 5th minute after birth (patient 6), one
child only in 1st minute (patient 8), and 9 other children
had normal Apgar score. Because of premature rupture
of amniotic membrane and amniotic fluid leak during the
period of 7 hours before birth with increasing inflamma-
tion parameters, patient 11 received antibiotic treatment.
Causative pathogen was not bacteriologically proven.
All children had dysmorphic features typical of Down
syndrome at birth. Cytogenetic analysis demonstrated a
regular trisomy 21st. Two children have karyotype 47,
XX+1 (patients 5 and 11), the other nine have karyotype
47, XY+1.
Congenital heart disease was found in 9/11 children.
There was no need of surgical treatment in 8/9 children,
because the shunt had no evident affect on hemodyna-
mics. In one child (patient 6) surgical correction of heart
disease (AV canalis communis) was required. The first
surgery was performed at the age of 6 months (1.5
months before the infantile spasms), and the second at
age of 3 years and 4 months. After the first surgery there
was no prolonged hypoxia. This child died at age of 4
years and 3 months due to cardiopulmonary failure.
Only one child (patient 5) has a positive family history
of epilepsy in second-degree relative. Before IS not one
child had any other types of attacks.
Infantile spasms began at the age of 5 to 10.5 months
in 10 of our patients, in one child at the age of 16 months
(patient 10). Seizures repeated daily, often in clusters
several times a day, while awake, often after awakening,
as flexion type. In one child IS were very mild (patient 9).
Only one child had perinatal risk factors for the devel-
opment of IS. It is a male child with intrauterine growth
retardation, induced birth at 37 weeks of gestation, birth
weight 2150 g, birth length 47 cm, Apgar score 6/7 and
AV canalis communis heart disease, which is surgically
treated (patient 6). Perinatal factors in some of our pa-
tients were low risk for the development of IS.
All children had abnormal EEG in term of hypsarr-
hythmia. During treatment hypsarrhythmia disappeared
in all patients (Figure 1a and 1b). Neuroimaging analysis
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TABLE 1














1/M 10:7 GA 34; elev. bil.; PT 6.5 HA
VGB. LTG.
VPA. CZP
9.5 mo 9:4/No No




10 mo/10d 9:5/No No
3/M 5:7 GA 38; VSD; ASD II 10 HA
VPA. VGB.
ACTH
7 mo/12 d 4:3/No VPA
4/M 4:7 GA 39; ASD II (FOA) 5 HA
VGB. VPA.
ACTH
1 mo/10 d 4:1/No VPA
5/F 3:4 GA 39; ASD II 6 HA VPA. ACTH 3 mo/7 d 2:7/No VPA
6/M *
GA 37; Apgar 6/7;
IUGR; A-V canalis
communis
7.5 HA VPA. ACTH 4 mo/28 d 4:3/No *
7/M 7:6





3.5 mo/28 d 6:9/No No
8/M 5:1 GA 38; Apgar 7/8; DAP 10.5 HA VPA. ACTH 1.5 mo/22 d 4:1/No VPA
9/M 4:2 GA 38; FOA 5.5 HA VPA. ACTH 2 mo/15 d 3:6/No VPA
10/M 4:10 GA 38; IUGR 16 HA VPA. ACTH 1 mo/10 d 3:5/No VPA
11/F 4:1
GA 37; SC; elev. bil.;
PT; VSD; ASD II
8.5 HA VPA. ACTH 5 mo/17 d 3:0/No VPA
GA – gestation age, VSD – ventricular septal defect, VPA – valproic acid, ASD – atrial septal defect, VGB – vigabatrin, FOA – foramen
ovale apertus, TPM – topiramate, DAP – ductus arteriosus persistens, LTG – lamotrigine, IUGR – intrauterine growth retardation,
CZP – clonazepam, ACTH – adrenocorticotropic hormone, HA – hypsarrhythmia
was done with computed tomography (CT) in 7, and mag-
netic resonance imaging (MRI) in 2 children. All had cor-
tical atrophy. In two children only intracranial ultra-
sound was performed, which was normal (patients 1 and
9). Treatment of IS in the first 5 patients started in other
hospitals (Table 1). Vigabatrin (VGB) was the initial
therapy in three children (patient 1, 2 and 4). Due to the
unsuccessful treatment in two children lamotrigine (LTG)
was added, and in one of them topiramate (TPM). Val-
proic acid (VPA) was the initial therapy in two of five
children (patients 3 and 5), one was added VGB. Nor in
one child the cessation of seizures occurred, hypsarrhy-
thmia persisted in EEG. The remaining six children were
treated in our Hospital from the beginning of the disease
(Table 1). Valproic acid was the initial therapy in all. Af-
ter 8–10 days of VPA application, as the therapy failed,
ACTH therapy was implemented in all 6 children and in
4 of 5 children who were initially treated in other institu-
tions. We used a synthetic ACTH (Synachten Depot
tetracosactide with zinc chloride) in a dose of 5 IU/kg
body weight intramuscular every other day during pe-
riod of 4 weeks in 8 children. Lower dose of ACTH, due to
side effects, but also for persisting of epileptogenic poten-
tials in EEG, one child received for 5 weeks (patient 8),
and one for 6 weeks (patient 10). In 6 children IS stopped
between 7th and 15th day from the beginning of ACTH
therapy, and in 4 children until 28 days of treatment.
Only one boy was not treated with ACTH. Because of
contact with varicellae, ACTH was postponed. Stabiliza-
tion of the disease occurred after the application of VPA
and clonazepam (previous therapy with VGB and LTG
was abolished).
During the application of ACTH in two children we
had to reduce the dose because of arterial hypertension
(patient 8) and pneumonia (patient 10). In two children
(patients 4 and 5) we reduced the dose because the thera-
peutic effect was very good (seizure free and satisfactory
improvement of EEG findings) in order to minimize the
possibility of side effects.
Arterial hypertension appeared in three children dur-
ing ACTH therapy, 7 had mild electrolyte unbalance (low
potassium and alkalosis). Four children had mild respira-
tory infection, one child had bronchiolitis and three
pneumonia.
During the follow-up period (from 2 years and 7
months to 9 years and 5 months), and after completing
corticosteroid therapy, no child had other types of at-
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Fig. 1a and 1b. EEG of patient 10 before (left) ACTH therapy showing hypsarrhythmia and after (right) ACTH therapy showing only
slow brain activity but any paroxysmal abnormalities.
tacks. On the final evaluation, in only one child EEG reg-
istered epileptogenic focal potentials (patient 8).
Antiepileptic therapy was discontinued in four chil-
dren at the age of 4 years and 2 months to 5 years.
Among them was a boy (patient 6) who died. Other 7 chil-
dren received antiepileptic therapy at the last outpatient
visit.
Discussion
Infantile spasms represent a particular type of sei-
zures that affect axial muscles, causing flexion, exten-
sion, or mixed. Variants of IS are described, with the em-
phasis that they can be very subtle, isolated and obscure
for long time7,10. IS may present in clusters, in infancy or
early childhood. In infancy are often associated with
hypsarrhythmia in EEG11. Spasms can be part of the epi-
leptic syndrome, or as a separate type of seizure charac-
teristic in some chronic epileptic conditions. Infantile
spasms, hypsarrhythmia in EEG and psycho-motor re-
tardation in development are known as West syndrome
(WS)12. According to the classification of epilepsies and
epileptic syndromes of International league against epi-
lepsy (ILAE) from 1989, WS is included in the age de-
pendent, generalized epilepsies and syndromes, crypto-
genic or symptomatic etiology13. Osborne et al. (2001)
proposed the use of the term non-symptomatic, secession
of the term cryptogenic and idiopathic, and for the etiol-
ogy or cause of WS accent the relationship with primary
disease14. Among the known diseases and conditions that
may be associated with about 2/3 WS are chromosomal
abnormalities such as DS.
We presented 11 children suffering from DS with in-
fantile spasms. Very subtle, hardly noticeable IS were in
one child. The other 10 children had a flexion type of IS.
In our group, there were significantly more male chil-
dren (9/11) than female. In some studies, there was more
affected males4,8,9,15 in other females16,17. Goldberg-Stern
et al. stated that of 350 people suffering from DS, aged
0–20 years, genetically confirmed, 28 (8%) had epilepsy3.
Partial seizures had 13 (47%), primarily generalized to-
nic-clonic 6 (21%) and infantile spasms 9 (32%) children,
of which 8 male and 1 female3.
Infantile spasms were reported in DS children with
regular trisomy 21, as well as with translocation and mo-
saic form of DS15,16,18. Karyotype of all our patients
showed a regular form of trisomy 21st.
Infantile spasms may be precipitated by relatively
common medical complication of DS: perinatal hypo-
xia-ischemia, infection and hypoxia due to congenital
heart disease. Stafstrom and Konkal described a group of
17 children with DS who had IS. In 14 of 17 children eti-
ology was not identified15. Two children had a perinatal
hypoxic-ischemic brain damage, a third child, after sur-
gery of congenital heart disease, also developed hypoxic
brain damage15. Silva et al. described 14 children with
DS who had IS. No child had perinatal brain damage, or
congenital cardiomyopathy16. In our group, one child had
perinatal hypoxia and congenital heart disease that was
surgically corrected 1.5 months before the start of IS.
There were no complications during and even after sur-
gery. In the majority of our patients as well as in reports
from the literature, no etiological factor for IS except DS
was found1,9,15,16,18,19. Stafstrom (1993) presented in re-
view article background knowledge about neuropatho-
logy and neurophysiology of the brain in DS, with special
emphasis on characteristics that could increase the pre-
disposition for seizures20. Structural abnormalities in-
clude frontal and temporal lobe hypoplasia, reduction of
brain volume at birth, which with increasing age reduces
even more. The most characteristic finding is the narrow
upper temporal gyrus. Neocortex contains 20–50% less
granular cells, especially in layers II and IV. Granular
cells are typical small inhibitory GABA-ergic cortical
interneurons. Their reduction can change the balance in
favor of excitation cortical networks. Branching of den-
drites is reduced, the total number dendritic spins are
smaller, and the existing have altered appearance (often
with a long thin neck). Reduction in the number of spins
can contribute to the emergence of abnormal tendency to
seizures. Neuronal membranes are pathologically hyper-
excitabile due to changes in the ion channels. Although
the exact mechanism for the increased tendency to sei-
zures in children with DS is still unknown, the available
facts point to a joined pathological interaction of hyper-
excitabile membrane properties (ion channels), changed
neuronal structure (pathological dendritic spine and syn-
aptic density is smaller) and abnormal neurotransmis-
sion inhibitors (less inhibitory interneurons)20. However,
since not all children with DS have seizures, most likely
there are other factors involved. All our patients had
epileptogenic changes in EEG. Changes corresponded to
hypsarrhythmia that vanished after adding of ACTG to
exiting antiepileptic drugs (AED) in 10/11 patients, and
in one after oral AED (Patient 1.).
Treatment of our patients was conducted in accor-
dance with the recommendations about the treatment of
IS and WS21–23. Initial treatment with VGB in 3 of our pa-
tients was not effective. Nabbout et al. reported that IS
stopped within 2 weeks from the application of VGB in 4
of 5 children. During the follow-up period of 2–4 years
there was no recurrence of IS or occurrence of other
types of seizures. One child was excluded from the study
because IS did not stop on VGB, the child was treated
with corticosteroids and VPA9. Infantile spasms in 8 of
our patients did not stop after the initial treatment with
valproic acid. Only after adding of synthetic ACTH in 10
patients, disappearance of IS and hypsarrhythmia oc-
curred. Hancock et al. (2008) analyzed the results of the
treatment of IS in 14 published studies. They concluded
that hormonal treatment leads to rapid disappearance of
IS in the larger number of children compared to VGB,
which may be drug of choice in tuberous sclerosis24. Ben-
eficial effect of vitamin B6 on IS in the Down syndrome
was described. The authors believe that oral application
of vitamin B6 in doses of 25–50 mg/kg/day as mono or
add on therapy in combination with classic antiepileptic
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drugs would be the first therapy in patients with IS and
DS25.
In accordance with the present knowledge on the
treatment of IS, we recommend to start treatment with
vigabatrin, but if the seizures do not cease to carry out
the treatment with ACTH.
Our children with DS and IS have had favorable out-
come. During the follow-up period (from 2 years and 7
months to 9 years and 5 months) none of our children de-
veloped another type of seizures. Three children no lon-
ger take AEDs, 7 still have therapy, and they are all on
mono therapy with VPA. Antiepileptic therapy was also
discontinued in a boy before his lethal outcome. On the
final evaluation only one of our patients has had EEG fo-
cal epileptogenic graphoelements. Half of 14 children
with DS and IS without congenital cardiomyopathy and
perinatal hypoxic-ischemic insult, which are described by
Silva et al., did not develop another type of seizures after
the cessation of IS. The second half had other types of
seizures, in which in 5 cases seizure control was rela-
tively easy accomplished with conventional antiepileptic
drugs16. In the report from Stafstrom and Konkola, 3/16
children with DS and IS have persistent epilepsy15. On
the final evaluation (follow-up period 11–114 months)
persistent attacks had 5/18 children, reported by Eiser-
mann et al.19. Favorable outcome in children with IS and
DS is described in other reports17,26,27.
Conclusion
Infantile spasms are the most common type of sei-
zures in children with Down syndrome. According to the
current classification of Epilepsy and epileptic syndro-
mes of ILAE since 1989, IS associated with Down syn-
drome are categorized in symptomatic group. The exis-
tence of cerebral pathology and delayed psycho-motor
development precedes occurrence of seizures. It is possi-
ble to achieve good control of infantile spasms and disap-
pearance of hypsarrhythmia using ACTH and conven-
tional antiepileptic drugs.
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INFANTILNI SPAZMI U DJECE S DOWN SINDROMOM
S A @ E T A K
Downov sindrom (DS) naj~e{}i je geneti~ki uzrok mentalne retardacije. Procjenjuje se da 5–13% osoba koje boluju od
DS ima konvulzije. Infantilni spazmi naj~e{}i su tip napadaja i obi~no dobro kontrolirani steroidima i antiepilepticima.
Prikazujemo 11 djece u dobi od 3 godine i 4 mjeseca do 10 godina i 7 mjeseci, s DS i infantilnim spazmima, koja su
lije~ena u Klinici za dje~je bolesti Zagreb od sije~nja 2000. do srpnja 2009. godine. Infantilni spazmi po~eli su u dobi od 5
do 10,5 mjeseci u 10 djece, u jednog djeteta u dobi 16 mjeseci. Samo jedno dijete imalo je i perinatalne ~imbenike rizika
za razvoj IS. Promjene u EEG odgovarale su hipsaritmiji. Infantilni spazmi inicijalno su lije~eni antiepilepticima, naj-
~e{}e valproatom. Lije~enje nije bilo u~inkovito u 10/11. Nakon primjene ACTH infantilni spazmi su prestali izme|u 7. i
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15. dana u 6, a do 28 dana u 4 djece. Hipsaritmija se izgubila u sve djece. Tijekom perioda pra}enja (2 godine i 7 mjeseci
do 9 godina i 5 mjeseci) niti jedno dijete nije razvilo drugi tip napadaja. Nisu registrirane niti ve}e epileptogene pro-
mjene u EEGu. Antiepilepti~ka terapija ukinuta je u 4 djece (u dobi od 4 godine i 2 mjeseca do 5 godina). U toj grupi je i
dje~ak koji je umro zbog sr~ane insuficijencije. Infantilni spazmi povezani s DS spadaju u simptomatsku grupu. Pojavi
napadaja prethodi usporen psihomotori~ki razvoj i postojanje cerebralne patologije. Mogu}e je posti}i dobru kontrolu
napadaja i nestanak hipsaritmije primjenom ACTH i antiepileptika.
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